Ingredient Guide
Hyaluronic Acid: Benefits, Dosage, and What the Research Says
Your body's built-in moisturizer - backed by over a dozen human clinical trials
Written by Jessica Medson
Hyaluronic acid (HA) is a glycosaminoglycan produced naturally in the body that holds up to 1,000 times its weight in water, making it critical for skin hydration, joint lubrication, and eye moisture - a healthy adult carries approximately 15 grams distributed across these tissues. Endogenous HA production declines with age, and oral supplementation has now been tested in multiple randomized controlled trials: a 12-week double-blind RCT in 40 adults found that 120 mg/day of HA significantly reduced wrinkle depth (p=0.01) and improved skin moisture content (p=0.02) versus placebo, while a 2024 systematic review of 597 patients found that 9 of 11 clinical studies reported measurable improvements in joint pain and function from oral HA. The evidence base is strongest for skin hydration, credible but more modest for joint support, and still early-stage for dry eye and other uses.
What Is Hyaluronic Acid?
Hyaluronic acid (HA) - also called hyaluronan, or sold as sodium hyaluronate in supplement and cosmetic form - is a naturally occurring, non-sulfated glycosaminoglycan (a long-chain sugar polymer) synthesized in virtually every tissue of the human body. Unlike many supplement ingredients that are purely exogenous, HA is an endogenous molecule your body already makes and depends on for daily function.
Where it lives in the body
A healthy adult body contains roughly 15 grams of hyaluronic acid in total, distributed unevenly across tissues. About half resides in the skin (primarily the dermis), where it is essential for maintaining the hydrated, plump texture of healthy skin. Significant concentrations are also found in synovial fluid (the lubricating fluid in joints), the vitreous humor of the eye, cartilage, tendons, and connective tissue throughout the body.9
HA's defining physical property is its extraordinary water-retention capacity - a single gram of HA can hold up to six liters of water. This makes it the body's primary biological humectant, drawing and locking moisture into tissues to maintain their hydration, elasticity, and structural integrity.9
The aging problem
Endogenous HA synthesis declines progressively after the mid-20s. This gradual reduction is widely regarded as one of the key contributors to aging-related changes in skin (loss of firmness and moisture), joints (reduced synovial fluid viscosity), and eye dryness. By age 70, some estimates suggest skin HA content may fall to approximately 25% of youthful levels, though individual variation is considerable.
Where supplements come from
Commercial HA for oral supplements is produced by two main methods: bacterial fermentation (most commonly using Streptococcus equi) or extraction from rooster combs. Fermentation-derived sodium hyaluronate has become the industry standard for vegan-friendly and allergen-controlled formulations. Molecular weight (MW) is a critical variable: high-molecular-weight HA (HMW-HA, above 1,000 kDa) and low-molecular-weight HA (LMW-HA, below 500 kDa) differ in how they are absorbed after oral ingestion and how they interact with cellular receptors.1
How Does Oral Hyaluronic Acid Work?
A common question is whether swallowing HA makes any biological sense - after all, the digestive tract breaks down complex polymers. Research has shed meaningful light on how oral HA may reach its target tissues.
Absorption pathway
After oral ingestion, digestive enzymes and gut microbial hyaluronidases partially degrade high-molecular-weight HA chains into smaller oligosaccharide fragments. These fragments are absorbed across the intestinal epithelium and enter systemic circulation. Animal studies have reported that approximately 90% of ingested hyaluronan is absorbed, with a measurable fraction accumulating in skin and other connective tissues.10 Radiotracer studies in rodents have confirmed that dietary HA migrates into skin tissue, where it appears to stimulate fibroblasts to increase their own HA production.
Cellular mechanisms
HA exerts biological effects primarily through two cell-surface receptors: CD44 and RHAMM (Receptor for HA-Mediated Motility). These receptors are expressed on skin fibroblasts, chondrocytes (cartilage cells), synoviocytes (joint lining cells), and immune cells. Receptor binding by HA fragments can trigger downstream signaling that promotes cell proliferation, matrix production, and the modulation of inflammatory cytokines.9
In joint tissue, oral HA has been shown in preclinical studies to reduce serum and synovial fluid levels of pro-inflammatory cytokines and suppress matrix metalloproteinases (MMPs) - enzymes that break down cartilage components. These mechanisms are plausible bridges between oral supplementation and the joint comfort outcomes observed in human trials.1
Does molecular weight matter for supplements?
Emerging data suggest that HMW-HA demonstrates stronger anti-inflammatory signaling in preclinical models, while smaller fragments cross biological barriers more readily. A 2025 review noted superior outcomes with HMW-HA versus lower-MW variants in arthritis models.1 Direct head-to-head human trials comparing MW classes remain limited, so the practical relevance to supplement selection is not yet established with certainty.
Hyaluronic Acid for Skin Hydration and Appearance
Skin hydration is where oral HA has the strongest and most consistent body of human clinical evidence, with multiple independent double-blind, placebo-controlled trials producing convergent findings across different populations and supplement formulations.
What the research shows
One of the most-cited trials is a 12-week double-blind, placebo-controlled RCT by Hsu et al. (2021) that enrolled 40 healthy adults aged 35-64 years. Participants received either 120 mg/day of hyaluronan or placebo for 12 weeks. Key results in the HA group versus placebo:2
- Stratum corneum water content significantly higher at multiple facial measurement sites (p=0.02)
- Transepidermal water loss (TEWL) significantly reduced at 12 weeks (p=0.009)
- Wrinkle assessment scores improved significantly at both 8 weeks (p=0.02) and 12 weeks (p=0.01)
- No adverse events were attributed to HA supplementation
A 2025 RCT by Doleckova et al. enrolled 150 healthy Caucasian adults and compared 60 mg/day, 120 mg/day, and placebo for 12 weeks. The 120 mg/day group showed significant improvements in skin hydration, elasticity, TEWL, and periorbital wrinkle depth compared to placebo. The 60 mg/day dose produced comparable but more modest results, suggesting a dose-response relationship.7
A 2023 double-blind RCT by Gao et al. studied 129 women (divided into younger, 18-35 years, and older, 45-65 years, cohorts) receiving 100 mg/day or 200 mg/day of high-molecular-weight HA (300 kDa) versus placebo for 12 weeks. Both dosage groups showed significantly improved skin hydration within 2-8 weeks across both age groups, with epidermal thickness increases observed at week 12 in the 100 mg/day group.8 This is notable because it suggests oral HA benefits younger adults as well, not only those with age-related skin dryness.
A 2025 trial by Montero-Vilchez et al. using a 60 mg/day HA matrix ingredient in 50 completers found significantly improved skin brightness and hydration versus placebo at both 6 and 12 weeks; approximately 69% of the treatment group reported satisfaction versus 42% in the placebo group.4
An earlier RCT by Kawada et al. (2014) reported that 120-240 mg/day of hyaluronan significantly increased skin moisture versus placebo in female subjects over 6 weeks, with skin moisture benefits persisting for up to two weeks after supplementation ended - suggesting the effect involves more than simple direct hydration.10
Evidence tier: Tier A. Multiple independent human RCTs consistently show skin hydration and wrinkle improvements with oral HA at 60-200 mg/day over 8-12 weeks in both younger and older adults.
Hyaluronic Acid for Joint Comfort and Mobility
Hyaluronic acid is a major structural component of synovial fluid, where it provides the viscosity and elasticity needed for smooth joint movement. As HA concentration and molecular weight both decline during osteoarthritis (OA) progression, supplementing orally has been explored as a non-injection approach to joint support.
What the research shows
The most comprehensive synthesis of the oral HA-joint evidence is a 2024 systematic review by Carvalho and Davidson, which analyzed 11 published articles encompassing 597 patients. Participants ranged from ages 40-70, dosages ranged from 30-300 mg/day, and follow-up extended from 4 weeks to 12 months. The authors found that 9 of 11 studies reported measurable improvements in joint outcomes including VAS pain scores, WOMAC total scores, Lequesne index, joint function, and SF-36 quality of life. Two studies documented reductions in inflammatory cytokine levels following oral HA therapy. Adverse effects across all studies were described as "rare and mild." The authors concluded that oral HA "appears to be a safe and effective therapy for OA patients," while noting the need for more and larger trials.5
A 2025 narrative review with rat model and clinical data (Wang et al.) corroborated these findings, reporting that pooled clinical trial data shows oral HA "significantly decreased pain, stiffness, and physical function" scores on the WOMAC index, with HMW-HA showing the most pronounced benefit in preclinical models.1
A 2023 multicenter double-blind RCT by Hill et al. evaluated a combination supplement containing krill oil, astaxanthin, and oral HA in 100 participants (75 completing per-protocol analysis) with mild osteoarthritis over 12 weeks. The active group showed a mean VAS pain reduction of 20.8 mm versus 10.6 mm in the placebo group (p=0.0105), and WOMAC total scores improved significantly more in the active group (p=0.0489). Adverse event rates were actually lower in the treatment group (4% vs. 16%, p=0.0455). It is important to note that this product contained multiple active ingredients, so HA's independent contribution cannot be isolated from this trial.3
Evidence tier: Tier A (individual studies); the overall evidence base is consistent but the number of large, high-quality standalone oral HA trials remains modest. Oral HA is not a substitute for intra-articular (injected) HA, which delivers far higher local concentrations - direct comparisons between routes have not been conducted in well-powered trials.
Oral Hyaluronic Acid and Eye Comfort
Topical sodium hyaluronate eye drops are a well-established, evidence-backed treatment for dry eye disease (DED). Oral HA as an adjunct for eye comfort is a newer and far less studied application, with only a small number of clinical investigations completed.
What the research shows
A 2019 pilot RCT by Kim et al. is the primary published human trial in this area. The study enrolled 54 participants with dry eye disease: all received standard topical HA eye drops, while 24 participants were additionally supplemented with 240 mg/day of oral sodium hyaluronate (390 kDa) for 3 months. Compared to the topical-only group, the oral-plus-topical group demonstrated:6
- Significant improvement in OSDI symptom scores (61.8 at baseline to 42.3 at 3 months; p<0.001)
- Significantly improved tear film break-up time (TBUT) at 1 month (p=0.005) and 3 months (p=0.012)
- Significant reduction in corneal fluorescein staining from 1.8 to 0.8 (p<0.001), indicating improved corneal surface healing
The authors described oral HA as helping more efficiently improve corneal epithelial wound healing compared to topical therapy alone. No serious adverse events were reported.
Evidence tier: Tier B. This is a single small pilot RCT. Oral HA was used as an adjunct to topical HA, not as a standalone treatment. Dry eye is a complex condition with multiple subtypes. These preliminary findings are promising but not sufficient for confident recommendations; more well-powered, independently replicated trials are needed.
Safety, Side Effects, and Interactions
Oral hyaluronic acid has a well-documented safety record across human clinical trials lasting up to 12 months. In the 2024 systematic review covering 597 patients, adverse effects were described as "rare and mild" with no serious events attributed to oral HA across the included studies.5 In the 150-adult RCT by Doleckova et al. (2025), no statistically significant difference in adverse events was observed between the 120 mg/day sodium hyaluronate group and placebo over 12 weeks.7
Known considerations
- Avian allergy: Some oral HA products are derived from rooster combs. Individuals with known hypersensitivity to poultry or avian products should choose fermentation-derived (non-avian) sodium hyaluronate and confirm sourcing with the manufacturer.
- Gastrointestinal effects: Mild GI symptoms (bloating, nausea) have been occasionally reported in trials, though frequencies were not meaningfully different from placebo rates.
- Pregnancy and breastfeeding: No well-designed human trials have evaluated oral HA safety during pregnancy or lactation. Topical HA is widely used and considered low-risk, but oral systemic effects in these populations are not established. Consult a healthcare provider before use.
- Cancer considerations: HA binds the CD44 receptor, which is overexpressed on certain cancer cell lines in preclinical models. This raises a theoretical concern about HA supplementation in individuals with active malignancy or a history of CD44-expressing cancers. No human trial evidence demonstrates harm from oral HA supplements in this population, but clinician guidance is prudent.
- Drug interactions: No clinically documented pharmacokinetic or pharmacodynamic interactions between oral HA supplements and prescription medications have been established in the published literature. Theoretical interactions with hyaluronidase-modifying agents exist but are undocumented in practice.
- After dermal filler procedures: If you have recently received HA-based dermal filler injections, consult your provider before beginning oral HA supplements. The interaction between systemic supplementation and locally injected HA deposits has not been studied.
In long-term rodent toxicology studies, the no-observed-adverse-effect level (NOAEL) for oral sodium hyaluronate was established above 48 mg/kg/day - a margin well above typical human supplement doses of 60-200 mg/day. This preclinical safety data, combined with the clean adverse-event profile across multiple human RCTs, supports the general tolerability of oral HA in healthy adults. As with any supplement, individuals managing chronic conditions or taking prescription medications should discuss use with their healthcare provider before starting.
Oral Hyaluronic Acid Dosage by Goal
Doses below reflect ranges used in published clinical trials. No regulatory body has established a recommended daily intake for oral HA. These are research-informed reference points, not prescriptions.
| Goal | Typical Dose | Timing | Notes |
|---|---|---|---|
| Skin hydration and wrinkle reduction | 120 mg/day | Morning, with or without food | Most human RCTs used 120 mg. A 60 mg dose showed measurable but more modest results. Allow 8-12 weeks for meaningful improvement. |
| Joint comfort (osteoarthritis support) | 80-200 mg/day | Morning, or split into two doses | Range used in positive clinical trials. No human dose-response trial has identified an optimal dose for joint outcomes specifically. Allow 4-12 weeks. |
| Dry eye symptom support (adjunctive) | 240 mg/day | Split: morning and evening | Dose used in the sole pilot RCT (Kim et al., 2019), where oral HA was combined with topical HA eye drops - not tested as a standalone. Evidence tier B only. |
Start at the lower end of the studied range (60-120 mg/day) and assess tolerability before increasing. Doses above 300 mg/day have not been well studied in humans and offer no established additional benefit based on current evidence.
What the Evidence Shows at a Glance
The table below summarizes what published human clinical research shows for each commonly studied use of oral hyaluronic acid, along with the strength of that evidence.
| Outcome | What Studies Show | Evidence Strength |
|---|---|---|
| Skin hydration | Significant improvement vs. placebo at 60-120 mg/day over 8-12 weeks; reduced TEWL and improved moisture content across multiple independent RCTs | Tier A - multiple RCTs |
| Skin wrinkle reduction | Significantly reduced periorbital wrinkle depth in double-blind trials; measurable improvement as early as 8 weeks at 120 mg/day | Tier A - multiple RCTs |
| Joint pain / OA symptom relief | 9 of 11 studies in a 597-patient systematic review reported improvements in VAS pain, WOMAC, and joint function; effect sizes are modest | Tier A (consistent studies); effect sizes modest |
| Dry eye symptoms (adjunctive use) | Oral HA plus topical HA improved OSDI scores and tear film break-up time vs. topical-only control in a 54-person pilot RCT | Tier B - single small pilot study |
| Anti-inflammatory and cartilage effects | Reduced pro-inflammatory cytokines and matrix metalloproteinases in animal models; 2 human studies also showed cytokine reductions | Tier B/C - animal models + limited human data |
Tier A = human RCT or meta-analysis. Tier B = human observational or small/single pilot RCT. Tier C = animal or in-vitro data only; human evidence not established.
Frequently Asked Questions
What is hyaluronic acid good for?
Oral HA supplements have the strongest research support for skin hydration and reducing wrinkle depth. Multiple RCTs show meaningful skin moisture improvements over 8-12 weeks. There is also consistent but more modest evidence for joint comfort in mild osteoarthritis, and early-stage data suggesting a possible adjunctive benefit for dry eye symptoms when combined with topical eye drops.
How much hyaluronic acid should I take per day?
The most studied and supported oral dose is 120 mg/day, which appears in the majority of positive skin hydration and joint RCTs. Doses as low as 60 mg/day have shown measurable skin benefits, and some joint trials used up to 200-300 mg/day. No dose above 300 mg/day has been well-studied, and no regulatory body has set a recommended intake.
Does oral hyaluronic acid actually work for skin?
Yes, based on multiple independent double-blind, placebo-controlled RCTs. A 12-week trial in 40 adults found 120 mg/day significantly reduced wrinkle depth (p=0.01) and improved skin moisture (p=0.02) versus placebo. A 150-adult RCT in 2025 replicated this, and a 129-woman trial confirmed benefits for both younger and older adults within 2-8 weeks.
Can hyaluronic acid help with joint pain?
Research suggests it may help maintain joint comfort. A 2024 systematic review of 597 patients found 9 of 11 clinical studies reported improvements in pain and function scores from oral HA at 30-300 mg/day over 4 to 12 months. Effect sizes tend to be modest, and oral HA is not equivalent to intra-articular (injected) hyaluronic acid, which delivers far higher local concentrations.
What are the side effects of hyaluronic acid supplements?
In clinical trials lasting up to 12 months, adverse effects from oral HA were described as rare and mild. Occasional GI symptoms (nausea, bloating) have been mentioned, but at rates not significantly different from placebo. Individuals with avian or poultry allergies should choose fermentation-derived formulations. No serious adverse events have been attributed to oral HA in published human trials.
Is it safe to take hyaluronic acid every day?
Published RCTs have administered oral HA daily for up to 12 months with a clean safety profile. In animal toxicology studies, the no-observed-adverse-effect level (NOAEL) exceeded 48 mg/kg/day - well above typical human doses. Daily use at studied doses (60-200 mg/day) appears safe for healthy adults, though those with a history of cancer, active malignancy, or pregnancy should consult a physician first.
How long does it take for hyaluronic acid supplements to work?
Skin benefits have been measurable as early as 6-8 weeks in RCTs, with maximal improvements typically seen at the 12-week mark. One study noted that 2 weeks of skin moisture benefits persisted even after supplementation ended. For joint outcomes, trials report improvements appearing at 4-8 weeks, with some studies extending to 12 months. Results vary by individual.
What is the difference between hyaluronic acid and sodium hyaluronate?
They are the same core molecule. Sodium hyaluronate is the sodium salt form of hyaluronic acid - the form most commonly used in oral supplements and topical cosmetics. Sodium hyaluronate has a slightly lower molecular weight and is more water-soluble, which may improve absorption from supplements. For practical purposes, the two terms are used interchangeably in the supplement context.
Can oral hyaluronic acid supplements replace HA injections?
No. Intra-articular HA injections deliver concentrated HA directly to the joint space, achieving local tissue concentrations many times higher than oral supplementation can reach systemically. Similarly, HA-based dermal fillers create localized volume effects that a supplement cannot replicate. Oral HA works through systemic circulation and may support general tissue HA levels, but it is a different modality with a different evidence base.
Does molecular weight of hyaluronic acid matter in supplements?
It may. High-molecular-weight HA (HMW-HA, above 1,000 kDa) shows stronger anti-inflammatory properties in preclinical models, while low-molecular-weight fragments may absorb more readily across the gut lining. A 2025 review found HMW-HA outperformed lower-MW variants in animal joint models. However, head-to-head human trials comparing molecular weight classes in supplements are limited, so definitive guidance is not yet possible.
Shop Hyaluronic Acid
HealthFare Hyaluronic Acid supplements
Scientific References
- 1.Wang B, Wang F, Zhang T, Bai J, Cui S, Shi H Role of oral hyaluronic acid for joint health: insights from rat models and clinical trials. Frontiers in Nutrition. 2025. PubMed: 41479667Human observational
- 2.Hsu TF, Su ZR, Hsieh YH, Wang MF, Oe M, Matsuoka R, Masuda Y Oral Hyaluronan Relieves Wrinkles and Improves Dry Skin: A 12-Week Double-Blinded, Placebo-Controlled Study. Nutrients. 2021. PubMed: 34203487Clinical (RCT / meta-analysis)
- 3.Hill WS, Dohnalek MH, Ha Y, Kim SJ, Jung JC, Kang SB A Multicenter, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate the Efficacy and Safety of a Krill Oil, Astaxanthin, and Oral Hyaluronic Acid Complex on Joint Health in People with Mild Osteoarthritis. Nutrients. 2023. PubMed: 37686801Clinical (RCT / meta-analysis)
- 4.Montero-Vilchez T, Galvez-Martin P, Sanabria-de la Torre R, Cuenca-Barrales C, Molina-Leyva A, Martinez-Puig D, Velasco-Alvarez J, Arias-Santiago S Oral Supplementation with a New Hyaluronic Acid Matrix Ingredient Improves Skin Brightness, Hydration, Smoothness, and Roughness: Results from a Randomized, Double-Blinded, Placebo-Controlled Study. Dermatology and Therapy. 2025. PubMed: 40498387Clinical (RCT / meta-analysis)
- 5.Carvalho JF, Davidson J Oral Hyaluronic Acid in Osteoarthritis and Low Back Pain: A Systematic Review. Mediterranean Journal of Rheumatology. 2024. PubMed: 39886281Clinical (RCT / meta-analysis)
- 6.Kim Y, Moon CH, Kim BY, Jang SY Oral Hyaluronic Acid Supplementation for the Treatment of Dry Eye Disease: A Pilot Study. Journal of Ophthalmology. 2019. PubMed: 31662894Human observational
- 7.Doleckova I, Kusnierik P, Berka V, Simek M, Matejkova I, Prokopec F, Ovesna P Oral sodium hyaluronate improves skin hydration, barrier function and signs of aging: a randomized, double-blind, placebo-controlled trial in 150 healthy adults. Scientific Reports. 2025. PubMed: 41422283Clinical (RCT / meta-analysis)
- 8.Gao YR, Wang RP, Zhang L, Fan Y, Luan J, Liu Z, Yuan C Oral administration of hyaluronic acid to improve skin conditions via a randomized double-blind clinical test. Skin Research and Technology. 2023. PubMed: 38009035Clinical (RCT / meta-analysis)
- 9.Gupta RC, Lall R, Srivastava A, Sinha A Hyaluronic Acid: Molecular Mechanisms and Therapeutic Trajectory. Frontiers in Veterinary Science. 2019. PubMed: 31294035Human observational
- 10.Kawada C, Yoshida T, Yoshida H, Matsuoka R, Sakamoto W, Odanaka W, Sato T, Yamasaki T, Kanemitsu T, Masuda Y, Urushibata O Ingested hyaluronan moisturizes dry skin. Nutrition Journal. 2014. PubMed: 25014997Clinical (RCT / meta-analysis)